Flint, MINCT07448038Now EnrollingIRB Ready

Atherosclerosis Clinical Trial in Flint, MI

Access cutting-edge atherosclerosis treatment through this clinical trial at a research site in Flint. Study-provided care at no cost to qualified participants.

Sponsored by Genentech, Inc.

Quick Self-Assessment

See if you qualify for this Flint location

Preparing your pre-screening questions…

Expert Care in Flint

Access atherosclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atherosclerosis treatment provided free

Apply for This Flint Location

Check if you qualify for this atherosclerosis clinical trial in Flint, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Flint

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Flint site if eligible
  4. 4Begin participation

About This Atherosclerosis Study in Flint

The main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for major adverse cardiovascular event (MACE), who are currently on standard-of-care (SOC) therapy.

Sponsor: Genentech, Inc.

Who Can Participate

Inclusion Criteria

Confirmed evidence of atherosclerosis
Left or right carotid TBR ≥ 1.8 or aorta TBR ≥ 2.0 on centrally-assessed 18F-fluorodeoxyglucose-Positron Emission Tomography (18F-FDG-PET) scan
Stable treatment of atherosclerosis through the use of SOC medications or revascularization
QT interval corrected through use of Fridericia's formula (QTcF) of ≤ 450 milliseconds (ms) in men and ≤ 470 ms in women by a single 12-lead electrocardiogram (ECG) recording

Exclusion Criteria

Individuals with Class III and IV heart failure
Uncontrolled cardiac arrhythmia
Uncontrolled hypertension
Suspected or known immunocompromised state
Planned procedure or surgery during the study and any major surgery within 90 days prior to screening Visit 1
History of malignancy within 5 years prior to screening, except for appropriately treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, or Stage I uterine cancer
Positive test results for hepatitis B (HBV) infection at screening
Positive hepatitis C virus (HCV) antibody test at screening
Positive human immunodeficiency virus (HIV) test at screening
Treatment with any live vaccine within 28 days prior to the first dose of study drug until the end of the study
Treatment with other non-live vaccines within 14 days prior to the first dose of study drug until the end of the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Flint?

Yes, this clinical trial (NCT07448038) has an active research site in Flint, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atherosclerosis Treatment Options in Flint, MI

If you're searching for atherosclerosis treatment options in Flint, MI, this clinical trial (NCT07448038) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Flint research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atherosclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Flint?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Flint, MI